Sökning: "Time in Therapeutic Range TTR"

Visar resultat 1 - 5 av 6 avhandlingar innehållade orden Time in Therapeutic Range TTR.

1. 1. Warfarin treatment quality in stroke prevention

   Författare :Fredrik Björck; Anders Själander; Peter Svensson; Per Wester; Christine Kremer; Umeå universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Anticoagulation; atrial fibrillation; complications; international normalized ratio INR variability; persistence; stroke; time in therapeutic range TTR ; treatment quality; warfarin; cardiovascular disease; hjärt- och kärlforskning;

   Sammanfattning : BackgroundIschemic stroke is a serious condition often associated to presence of atrial fibrillation (AF). Use of anticoagulants for AF patients greatly reduces the risk of stroke. Warfarin is the most commonly used anticoagulant in Sweden. The aim of this thesis was to study the impact of warfarin treatment quality in Swedish stroke prevention. LÄS MER

3. 2. Anticoagulation treatment in patients with a mechanical heart valve

   Författare :Bartosz Grzymala-Lubanski; Anders Själander; Peter J. Svensson; David Bergqvist; Umeå universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Mechanical heart valve; anticoagulation; warfarin; Time in Therapeutic Range TTR ; INR variability;

   Sammanfattning : BackgroundEvery year about 2,500 patients in Sweden undergo surgery for heart valve disease, primarily in the aortic valve.  In contrast to the mitral valve, which can be repaired in 70% of the cases, the aortic valve is normally replaced by a mechanical or biological prosthesis. LÄS MER

4. 3. Anticoagulants in kidney disease

   Författare :Frida Welander; Anders Själander; Henrik Holmberg; Emöke Dimény; Marie Evans; Umeå universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Anticoagulants; atrial fibrillation; chronic kidney disease; dialysis; DOAC; ischemic stroke; major bleeding; nephrotic syndrome; venous thromboembolism; warfarin.; Medicine; medicin;

   Sammanfattning : Background: Patients with chronic kidney disease (CKD) and atrial fibrillation (AF) are at high risk of ischemic stroke. Evidence is lacking if patients with advanced CKD or on dialysis benefit from oral anticoagulants (OAC) as stroke prophylaxis. LÄS MER

5. 4. Oral anticoagulation treatment in atrial fibrillation - To bleed or not to bleed, that is the question

   Författare :Mattias Wieloch; Malmö Institutionen för kliniska vetenskaper; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; anticoagulation; atrial fibrillation; hemorrhage; kidney; warfarin; epidemiology; stroke;

   Sammanfattning : Background: Oral antigoagulation treatment (OAT) with warfarin have a narrow therapeutic window and patients exhibit a highly variable doseresponse that is attributable to genetic, disease-related,and environmental factors as well as prescription and nonprescription drugs, dietary vitamin K and alcohol. The effect of warfarin treatement on blood coagulation is measured using international normalized ratio (INR). LÄS MER

7. 5. Management of Adults with Congenital Heart Disease

   Författare :Daniel Samarai; Kardiologi; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Adults with Congenital Heart Disease; Congenital Heart Disease; Congenital heart defect CHD ; Anticoagulation; Anticoagulants; anticoagulant treatment; Thromboembolic events; Major bleeding; Diagnostic Imaging methods;

   Sammanfattning : Adults with congenital heart disease (ACHD) are a completely new and rapidly growing specialty comprising patients who require specialist knowledge regarding their care and treatment. Challenges involve diagnostics and treatment as studies are scarce and include small and heterogenous study populations. LÄS MER